Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Medicine
    • India vulnerable to...

    India vulnerable to infectious diseases like Zika, Ebola

    Written by supriya kashyap kashyap Published On 2017-04-14T11:42:56+05:30  |  Updated On 14 April 2017 11:42 AM IST
    India vulnerable to infectious diseases like Zika, Ebola

    New Delhi : South Asian nations including India are "vulnerable" to emerging infectious diseases like Zika and Ebola and their level of preparedness is "inadequate" to protect public health, a new analysis said.


    Inadequate surveillance and uneven health system capacity may accelerate the spread of the emerging infectious diseases in the region, which is already burdened by diseases like tuberculosis, HIV and malaria, an analysis as part of a collection of twelve analyses on health in South Asia published in British Medical Journal (BMJ) said.


    The analysis pointed out that although sporadic cases of dengue infection were seen in many South Asian countries in the 1960s, regular epidemics only occurred in the early 1990s in India and Sri Lanka.


    "In India and Sri Lanka, by around 40 years of age 90-95 per cent of adults have been infected with the dengue virus, while 41 per cent have been infected with chikungunya," it said.


    Noting that Anthrax is endemic in large parts of South Asia, the analysis said that in the border areas of India, Bangladesh, and Myanmar, poor vaccination and surveillance have been accompanied by "increasing" anthrax cases, which prompted Bangladesh to announce a "red alert" in 2010.


    Noting that rabies remains endemic in eight countries in South East Asia, with 1.4 billion people at risk, the authors in the analysis said that the region contributes about 45 per cent of global rabies deaths, while the "rhetoric" on elimination continues to grow.


    "Brucellosis, bovine tuberculosis, and a range of food- borne diseases contribute to the morbidity and mortality attributable to zoonotic infections but are struggling to gain the attention of policymakers in the subcontinent, despite it resulting in 150 million illnesses, 175,000 deaths, and 12 million disability-adjusted life years," the analysis said.


    The analysis found that the highly pathogenic avian influenza (HPAI) virus A/H5N1, which was introduced to the subcontinent in 2005 through wild birds, has since become endemic across large parts of northeast India and Bangladesh, across porous international borders.


    "It has resulted in losses of around USD 500 million," the analysis by Centre for Disease Dynamics, Economics and Policy (CDDEP) Director Ramanan Laxminarayan and colleagues said.


    "South Asia stands vulnerable to emerging infectious diseases. Examining the vulnerability to emerging and growing infectious disease threats and the capacity to respond to outbreaks, the analysis finds the level of preparedness is inadequate to protect public health," it said.


    South Asia is defined by the World Bank as Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan and Sri Lanka and is home to a quarter of the world's population.


    It bears a significant proportion of the global burden of infectious disease, with longstanding battles against TB, HIV and malaria.


    "Emerging and growing infectious diseases, like Zika, Ebola, MERS-CoV, and avian influenza, are adding to the already significant burden of disease, and their spread may accelerate in the face of factors such as inadequate surveillance and uneven health system capacity.


    "The current state of affairs appears to result from a severe policy neglect, including a general lack of commitment to the 'One Health' approach in policy discourse, which would consider the interrelation of animal health, human health, and the environment," the authors noted.


    The analysis found that Nipah virus emerged in Malaysia in the late 1990s, initially being misdiagnosed as Japanese encephalitis (JE), and there have since been frequent outbreaks in Bangladesh and to a lesser extent in India.


    They said the lack of preventive measures and surveillance has led to some previously sporadic diseases like Nipah virus and Chandipura virus becoming "endemic" in these countries.


    There has also been a marked rise in incidence, even as mortality rates have decreased, for some diseases, they said.


    "With rapid shifts in urbanisation and increasing population, South Asia has the opportunity and obligation to implement meaningful policy changes to prepare against emerging infectious diseases.


    "Millions of lives are at stake and betting against the spread of emerging infectious diseases would be irresponsible," said Laxminarayan.


    The analysis noted that the elimination of polio from many countries in the region, most recently in India, is a "landmark" achievement.


    "At the global scale, South Asia must become more engaged in the health security agenda. The government of India is a founder contributor to the Coalition for Epidemic Preparedness Innovation (CEPI), an initiative that aims to accelerate the development of new vaccines for high threat pathogens.


    "This leadership is commendable, but such research and development pipelines need to be linked to strengthened surveillance, response, and research platforms within South Asia to ensure that it can be evaluated and implemented locally. Finally, global science communities can help enhance regional conversation to encourage local collaboration," it added.

    British Medical JournalCDDEPEbolahighly pathogenic avian influenzaHIVHPAIInfectious diseasesJapanese EncephalitisMalariaRamanan LaxminarayanTuberculosisvulnerableZIKAZIKA Virus
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok